Recordati Industria Chimica e Farmaceutica SpA

F:RER1

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RER1's stock price target?

Price Target

60.78 EUR

According to Wall Street analysts, the average 1-year price target for RER1 is 60.78 EUR with a low forecast of 49.05 EUR and a high forecast of 75.43 EUR.

What is the Revenue forecast for Recordati Industria Chimica e Farmaceutica SpA?

Projected CAGR

7%

Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 7%.

What is the Gross Profit forecast for Recordati Industria Chimica e Farmaceutica SpA?

Projected CAGR

5%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 5%.

What is the Operating Income forecast for Recordati Industria Chimica e Farmaceutica SpA?

Projected CAGR

13%

Over the last 14 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 13%.

What is the Pre-Tax Income forecast for Recordati Industria Chimica e Farmaceutica SpA?

Projected CAGR

19%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 19%.

What is the Net Income forecast for Recordati Industria Chimica e Farmaceutica SpA?

Projected CAGR

20%

Over the last 14 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 20%.